Clearbridge Health Stock

Clearbridge Health Equity

The The Equity of Clearbridge Health (1H3.SI) as of Jul 26, 2026 is 9.22 M SGD. In the previous year, The Equity was 10.19 M SGD — a change of -9.57% (lower).

Equity

9.22 MSGD

YoY

-9.57%

Last updated:

In 2026, Clearbridge Health's equity was 9.22 M SGD, a -9.57% increase from the 10.19 M SGD equity in the previous year.

Access this data via the Eulerpool API

Clearbridge Health Stock analysis

What does Clearbridge Health do? Clearbridge Health Ltd is an international company in the healthcare and diagnostics sector based in Singapore. The company was founded in 2017 and focuses on the use of innovative technology, information, and communication systems to provide efficient and precise diagnostics and medical care. The business model of Clearbridge Health is based on a wide range of services and products, divided into three segments: Clinical diagnostics, healthcare services, and digitization. These divisions are interconnected and allow the company to offer a comprehensive range of healthcare services. In the field of clinical diagnostics, the company offers a variety of laboratory and radiology services. Clearbridge Health has a strong presence in Singapore and Indonesia, where it has several diagnostic laboratories specializing in areas such as pathology, microbiology, genetics, and molecular diagnostics. In addition, the company has partnerships with leading diagnostic laboratories worldwide to provide its customers with an even broader range of diagnostic options. In the healthcare services segment, Clearbridge Health offers a wide range of services including diagnosis, treatment, and disease prevention, as well as health management. A key focus in this area is the care of cancer patients. Here, the company has developed a unique self-financing model where it invests in diagnosis and treatment and benefits from the outcomes achieved. The goal is to provide cancer patients with fast diagnosis and comprehensive, personalized treatment. Clearbridge Health has partnerships with leading cancer centers worldwide and utilizes the latest technologies to enable fast and accurate diagnosis. In the digitization segment, Clearbridge Health offers innovative technology solutions to digitalize the healthcare sector and improve efficiency in healthcare delivery. One of the products includes a cloud-based platform for medical imaging called teleradiology. The platform allows for the digital transmission of images from one location to another, saving time and costs and improving efficiency in patient diagnosis and treatment. Clearbridge Health has experienced rapid growth in recent years. The company has expanded its presence in Asia and other parts of the world and continues to pursue an ambitious expansion strategy. The goal is to become a global leader in healthcare and diagnostics. In summary, Clearbridge Health is an innovative company in the healthcare and diagnostics sector that offers a wide range of services and products. The company has a strong presence in Asia and collaborates closely with leading diagnostic laboratories and cancer centers worldwide. Clearbridge Health is committed to improving healthcare delivery and promoting the adoption of innovative technology solutions to enhance efficiency. The company has experienced impressive growth in recent years and continues to pursue an ambitious expansion strategy. Clearbridge Health is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Clearbridge Health's Equity

Clearbridge Health's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Clearbridge Health's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Clearbridge Health's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Clearbridge Health's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Clearbridge Health’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Clearbridge Health stock

The Equity of Clearbridge Health is 9.22 M SGD in 2026.

Access this data via the Eulerpool API

Balance Sheet — Clearbridge Health

All Key Metrics — Clearbridge Health